Literature DB >> 28440327

Bladder cancer: Targeting oncofetal glycosaminoglycans.

Peter Sidaway.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28440327     DOI: 10.1038/nrurol.2017.57

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN: 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  1 in total

1.  An Oncofetal Glycosaminoglycan Modification Provides Therapeutic Access to Cisplatin-resistant Bladder Cancer.

Authors:  Roland Seiler; Htoo Zarni Oo; Davide Tortora; Thomas M Clausen; Chris K Wang; Gunjan Kumar; Marina Ayres Pereira; Maj S Ørum-Madsen; Mette Ø Agerbæk; Tobias Gustavsson; Mie A Nordmaj; Jamie R Rich; Nada Lallous; Ladan Fazli; Sherry S Lee; James Douglas; Tilman Todenhöfer; Shaghayegh Esfandnia; Dulguun Battsogt; John S Babcook; Nader Al-Nakouzi; Simon J Crabb; Igor Moskalev; Bernhard Kiss; Elai Davicioni; George N Thalmann; Paul S Rennie; Peter C Black; Ali Salanti; Mads Daugaard
Journal:  Eur Urol       Date:  2017-04-10       Impact factor: 20.096

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.